FibroGen Executives

FibroGen Management Team Effectiveness

The company has return on total asset (ROA) of (0.1842) % which means that it has lost $0.1842 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.1579) %, meaning that it created substantial loss on money invested by shareholders. FibroGen's management efficiency ratios could be used to measure how well FibroGen manages its routine affairs as well as how well it operates its assets and liabilities. The market capitalization of FibroGen is $36.49 Million. Roughly 70.35 percent of FibroGen outstanding shares are held by general public with 1.65 (percent) owned by insiders and only 28.0 % by other corporate entities. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company. Some institutional investors establish a significant position in stocks such as FibroGen in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of FibroGen, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

FibroGen Workforce Comparison

The company has Profit Margin (PM) of 25.99 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (4.99) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $4.99.

FibroGen Insider Trading

FibroGen Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as FibroGen often depends on how effective the management is. FibroGen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of FibroGen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the FibroGen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

If you are still planning to invest in FibroGen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FibroGen's history and understand the potential risks before investing.